The combination of naxitamab with or without sintilimab (anti-PD-1) for the treatment of refractory/progressive neuroblastoma: A prospective, non-randomized, multicenter trial.
Year: 2025
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: Suying Lu, Juan Wang, Yuwen Chen, Hong Liang, Jia Zhu, Tianyou Yang, Youxiang Zhang, Hui Jin, Yuan Qv, Mingqing Ji, Zhiqiang Zhan, Junting Huang, Feifei Sun, Zijun Zhen, Yi Que, Yizhuo Zhang
Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Hainan General Hospital, Guangzhou Women and Children Medical Center, University of Hong Kong - Shenzhen Hospital, University of Hong Kong, Sichuan Cancer Hospital, Jiangxi Pingxiang People's Hospital
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410816700